ERGEA BELFAST LIMITED

• ◆

  1 PSC ceased in last 24 months

  Significant control changed hands — see the Ownership section.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -0.2%

  £3,354,615 → £3,347,922

• Cash

  —

  Not reported

• Net assets

  +6.8%

  £7,389,141 → £7,894,130

  highest in 6 filed years

• Employees

  -25%

  4 → 3

• Operating profit

  +48.3%

  £452,940 → £671,768

• Profit before tax

  +48.6%

  £452,940 → £673,278

• Wages

  -77.6%

  £69,116 → £15,450

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. ERGEA BELFAST LIMITED 2023-03-01 → present
2. MEDIPASS BELFAST LTD. 2013-05-14 → 2023-03-01
3. HTI IRELAND LIMITED 2001-05-15 → 2013-05-14

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

Sopher + Co LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Directors have conducted a business review and have a reasonable expectation that the Company have adequate resources to continue in operational existence until 31 December 2026, which is more than 12 months from the date of approval of these financial statements. Even in a zero-growth scenario where no new business is added, the Company generates positive cashflows. A material proportion of the business comes from the NHS (backed by UK Government), and from long-term contracts providing certainty of income beyond the Going Concern assessment period. The Directors have assessed the political, economic, social and technology risks and believe the Company is well placed to successfully manage these risks. On the basis of their assessment of the above, they continue to adopt the going concern basis of accounting in preparing the annual financial statements for the 12 months from the date of approval of the financial statements (the going concern period).”

Group structure

1. ERGEA BELFAST LIMITED · parent
   1. Ergea Healthcare Leeds and Belfast Limited 100% · United Kingdom

Significant events

• “There have been no significant events affecting the Company since the year end.”
• “No adjusting or significant non-adjusting events have occurred between the 31 December reporting date and the date of authorisation.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

11

last 12 months

Capital events

0

last 24 months

Officers appointed

3

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.